| The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and … J Mair-Jenkins, M Saavedra-Campos, JK Baillie, P Cleary, FM Khaw, ... The Journal of infectious diseases 211 (1), 80-90, 2015 | 1228 | 2015 |
| Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual … SG Muthuri, S Venkatesan, PR Myles, J Leonardi-Bee, TSA Al Khuwaitir, ... The lancet Respiratory medicine 2 (5), 395-404, 2014 | 753 | 2014 |
| Long COVID in a prospective cohort of home-isolated patients B Blomberg, KGI Mohn, KA Brokstad, F Zhou, DW Linchausen, ... Nature medicine 27 (9), 1607-1613, 2021 | 632 | 2021 |
| Immune responses after live attenuated influenza vaccination KGI Mohn, I Smith, H Sjursen, RJ Cox Human vaccines & immunotherapeutics 14 (3), 571-578, 2018 | 166 | 2018 |
| Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children KGI Mohn, G Bredholt, KA Brokstad, RD Pathirana, HJ Aarstad, C Tøndel, ... The Journal of infectious diseases 211 (10), 1541-1549, 2015 | 88 | 2015 |
| Impact of neuraminidase inhibitors on influenza A (H1N1) pdm09‐related pneumonia: an individual participant data meta‐analysis SG Muthuri, S Venkatesan, PR Myles, J Leonardi‐Bee, WS Lim, ... Influenza and other respiratory viruses 10 (3), 192-204, 2016 | 82 | 2016 |
| An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers AS Madhun, PE Akselsen, H Sjursen, G Pedersen, S Svindland, ... Vaccine 29 (2), 266-273, 2010 | 68 | 2010 |
| Live attenuated influenza vaccine in children induces B-cell responses in tonsils KGI Mohn, KA Brokstad, RD Pathirana, G Bredholt, Å Jul-Larsen, ... The Journal of infectious diseases 214 (5), 722-731, 2016 | 58 | 2016 |
| Boosting of cross-reactive and protection-associated T cells in children after live attenuated influenza vaccination KGI Mohn, F Zhou, KA Brokstad, S Sridhar, RJ Cox The Journal of infectious diseases 215 (10), 1527-1535, 2017 | 55 | 2017 |
| Attack rates amongst household members of outpatients with confirmed COVID-19 in Bergen, Norway: a case-ascertained study K Kuwelker, F Zhou, B Blomberg, S Lartey, KA Brokstad, MC Trieu, ... The Lancet Regional Health–Europe 3, 2021 | 50 | 2021 |
| SARS-CoV-2–specific neutralizing antibody responses in norwegian health care workers after the first wave of COVID-19 pandemic: a prospective cohort study MC Trieu, A Bansal, A Madsen, F Zhou, M Sævik, J Vahokoski, ... The Journal of infectious diseases 223 (4), 589-599, 2021 | 48 | 2021 |
| Acriflavine, a clinically approved drug, inhibits SARS-CoV-2 and other betacoronaviruses V Napolitano, A Dabrowska, K Schorpp, A Mourao, E Barreto-Duran, ... Cell Chemical Biology 29 (5), 774-784. e8, 2022 | 43 | 2022 |
| Neuraminidase inhibitors and hospital length of stay: a meta-analysis of individual participant data to determine treatment effectiveness among patients hospitalized with … S Venkatesan, PR Myles, KJ Bolton, SG Muthuri, T Al Khuwaitir, ... The Journal of infectious diseases 221 (3), 356-366, 2020 | 40 | 2020 |
| Live-attenuated influenza vaccine induces tonsillar follicular T helper cell responses that correlate with antibody induction S Lartey, F Zhou, KA Brokstad, KGI Mohn, SA Slettevoll, RD Pathirana, ... The Journal of infectious diseases 221 (1), 21-32, 2020 | 33 | 2020 |
| Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children KGI Mohn, KA Brokstad, S Islam, F Oftung, C Tøndel, HJ Aarstad, RJ Cox The Journal of infectious diseases 221 (9), 1528-1537, 2020 | 32 | 2020 |
| Comparative analysis of influenza A (H3N2) virus hemagglutinin specific IgG subclass and IgA responses in children and adults after influenza vaccination A Manenti, SM Tete, KGI Mohn, Å Jul-Larsen, E Gianchecchi, E Montomoli, ... Vaccine 35 (1), 191-198, 2017 | 32 | 2017 |
| Immune responses in acute and convalescent patients with mild, moderate and severe disease during the 2009 influenza pandemic in Norway KGI Mohn, RJ Cox, G Tunheim, JE Berdal, AG Hauge, Å Jul-Larsen, ... PloS one 10 (11), e0143281, 2015 | 26 | 2015 |
| Safety, immunogenicity, efficacy and effectiveness of inactivated influenza vaccines in healthy pregnant women and children under 5 years: an evidence-based clinical review A Bansal, MC Trieu, KGI Mohn, RJ Cox Frontiers in Immunology 12, 744774, 2021 | 24 | 2021 |
| Symptom burden and immune dynamics 6 to 18 months following mild severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2): a case-control study EB Fjelltveit, B Blomberg, K Kuwelker, F Zhou, TB Onyango, KA Brokstad, ... Clinical Infectious Diseases 76 (3), e60-e70, 2023 | 23 | 2023 |
| Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination S Islam, KGI Mohn, F Krammer, M Sanne, G Bredholt, Å Jul-Larsen, ... Vaccine 35 (42), 5666-5673, 2017 | 20 | 2017 |
